title: [Endothelial relaxation factor in the development of diabetic nephropathy].
abstract: Progression of diabetic nephropathy is now associated with intrarenal hemodynamic disorders (renal hyperperfusion, hyperfiltration, intraglomerular hypertension). The cause of these disorders is unclear. It is supposed that the relaxation factor which is produced by the vascular endothelium (endothelial relaxation factor-ERF) and an endogenous nitrogen oxide (NO) can cause the above intrarenal hemodynamic alterations in diabetes mellitus. The production of ERF/NO in 35 patients with insulin-dependent diabetes mellitus who had varying severities of diabetic nephropathies were examined. These included the following groups: 1) patients without diabetic nephropathy (n = 9); 2) those with incipient diabetes mellitus (n = 12), 3) those with severe diabetes mellitus (n = 14). From groups 1 and 2, 5 patients with hyperfiltration were identified, their glomerular filtration rate were more than 140 ml/ml. The ability of the cells to produce ERF/NO was indirectly estimated, by determining the levels of human platelet guanylate cyclase in the presence of L-arginine, a NO precursor, the accumulation of cGMP in the cells and plasma. When L-arginine was present, the activity of guanylate cyclase was virtually unchanged in Group 1, but it was substantially increased in Groups 2 and 3, by reaching its peak in patients with hyperfiltration (Group 4). The platelet and plasma levels of cGMP corresponded to the enhancement of guanylate cyclase activity in the presence of L-arginine and increased as diabetic nephropathy progressed. Thus, it is suggested that there is ERF/NO hyperproduction in patients at a high risk for diabetic nephropathy (those having hyperfiltration). ERF/NO is likely to promote the dilation of glomerular arterioles, which results in the development of hyperfiltration and intraglomerular hypertension, causing diabetic nephropathy progression.
authors.forename: M V
authors.initials: MV
authors.lastname: Shestakova
authors.forename: I S
authors.initials: IS
authors.lastname: Severina
authors.forename: I I
authors.initials: II
authors.lastname: Dedov
authors.forename: A K
authors.initials: AK
authors.lastname: Ragozin
authors.forename: N N
authors.initials: NN
authors.lastname: Belushkina
authors.forename: I K
authors.initials: IK
authors.lastname: Riaposova
mesh_terms: D000293:Adolescent; D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000503:physiopathology; D003928:Diabetic Nephropathies / Q000209:etiology* / Q000503:physiopathology; D005919:Glomerular Filtration Rate; D006439:Hemodynamics; D006801:Humans; D008875:Middle Aged; D009569:Nitric Oxide / Q000502:physiology*
chemical_list: D009569:Nitric Oxide
vernacular_title: Endotelial'nyĭ faktor relaksatsii v razvitii diabeticheskoĭ nefropatii.